Plasma p-tau is increased in AD patients compared to controls and MCI individuals, discriminating AD demented patients from both cognitively unimpaired subjects and other NDDs with optimal diagnostic accuracy [91]. The gene discussed is MAPT; the disease is Alzheimer disease.